Insulin patch pumps are small digital devices that are modern alternatives to insulin injections. These computerized devices can be programmed to automatically deliver doses of insulin on a regular schedule during both the day and night. Both men and women of all ages can use a patch for diabetes, especially those with Type 1. According to the latest market study results, the global insulin patch pumps market stood at around USD 1,017 million in 2022 and is projected to rise to a worth of USD 1,998 million by 2029 end, thereby garnering a CAGR of 10.1% during 2023-2029. The demand for the insulin patch pumps is primarily driven by the growing prevalence of diabetes among the population. As per the data revealed by the International Diabetes Federation, around 552 million people across the globe are estimated to have diabetes by the year 2030.The demand for the insulin patch pumps is primarily driven by the growing prevalence of diabetes among the population. As per the data revealed by the International Diabetes Federation, around 552 million people across the globe are estimated to have diabetes by the year 2030.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global insulin patch pumps market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors' approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the delivery mode, type, distribution channel, and region. The global market for insulin patch pumps can be segmented by delivery mode: basal, bolus, basal-bolus. The basal segment captured the largest share of the market in 2022. Insulin patch pumps market is further segmented by type: disposable, reusable. The reusable segment held the largest share of the global insulin patch pumps market in 2022 and is anticipated to hold its share during the forecast period. Based on distribution channel, the insulin patch pumps market is segmented into: hospitals, online pharmacies, retail pharmacies, others. In 2022, the retail pharmacies segment made up the largest share of revenue generated by the insulin patch pumps market. On the basis of region, the insulin patch pumps market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Among these, North America was accounted for the highest revenue generator in 2022.
By delivery mode: basal, bolus, basal-bolus
By type: disposable, reusable
By distribution channel: hospitals, online pharmacies, retail pharmacies, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The global insulin patch pumps market report offers detailed information on several market vendors, including A. Menarini Diagnostics s.r.l, CeQur SA, Debiotech S.A., Embecta Corp. (spin-off from BD), EOFlow Co., Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Medtronic Plc, Medtrum Technologies Inc., Tandem Diabetes Care, Inc., Terumo Corporation, ViCentra B.V. (Kaleido), Ypsomed AG, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
• To analyze and forecast the market size of the global insulin patch pumps market.
• To classify and forecast the global insulin patch pumps market based on delivery mode, type, distribution channel, region.
• To identify drivers and challenges for the global insulin patch pumps market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global insulin patch pumps market.
• To identify and analyze the profile of leading players operating in the global insulin patch pumps market.
Why Choose This Report
• Gain a reliable outlook of the global insulin patch pumps market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.
TABLE OF CONTENTS FIGURES AND TABLES PART 1. INTRODUCTION ?? Report description ?? Objectives of the study ?? Market segment ?? Years considered for the report ?? Currency ?? Key target audience PART 2. METHODOLOGY PART 3. EXECUTIVE SUMMARY PART 4. MARKET OVERVIEW ?? Introduction ?? Drivers ?? Restraints PART 5. MARKET BREAKDOWN BY DELIVERY MODE ?? Basal ?? Bolus ?? Basal-bolus PART 6. MARKET BREAKDOWN BY TYPE ?? Disposable ?? Reusable PART 7. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL ?? Hospitals ?? Online pharmacies ?? Retail pharmacies ?? Others PART 8. MARKET BREAKDOWN BY REGION ?? North America ?? Europe ?? Asia-Pacific ?? MEA (Middle East and Africa) ?? Latin America PART 9. KEY COMPANIES ?? A. Menarini Diagnostics s.r.l ?? CeQur SA ?? Debiotech S.A. ?? Embecta Corp. (spin-off from BD) ?? EOFlow Co., Ltd. ?? F. Hoffmann-La Roche AG ?? Insulet Corporation ?? Medtronic Plc ?? Medtrum Technologies Inc. ?? Tandem Diabetes Care, Inc. ?? Terumo Corporation ?? ViCentra B.V. (Kaleido) ?? Ypsomed AG *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES DISCLAIMER
Publisher: Gen Consulting Company
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support